Retrospective Study
Copyright ©The Author(s) 2025.
World J Gastrointest Surg. Feb 27, 2025; 17(2): 103266
Published online Feb 27, 2025. doi: 10.4240/wjgs.v17.i2.103266
Table 3 Univariate analysis of factors affecting the development of a pancreatic fistula following radical gastrectomy for gastric cancer, mean ± SD
Factors
Groups
Pancreatic fistula group (n = 31)
Non-pancreatic fistula group (n = 127)
t/χ2 value
P value
Age (years)≥ 6020710.7560.384
< 601156
SexMale18700.0880.767
Female1357
DiabetesYes16309.4600.002
No1597
HypertensionYes6210.1400.708
No25106
HyperlipidemiaYes131614.3110.000
No18111
Hemoglobin (g/L)Normal291170.0120.912
Descend210
Albumin (g/L)Normal291210.0040.949
Descend26
History of abdominal surgeryYes370.1960.658
No28120
Operative time (hour)≤ 319840.2580.611
> 31243
Intraoperative pancreatic injuryYes141617.1770.000
No17111
Combined splenectomyYes424.7850.029
No27125
Combined splenectomy and partial pancreatectomyYes220.8320.362
No29125
Retro-pancreatic lymph node dissectionYes19601.9670.161
No1267
Scope of gastric resectionProximal stomach4180.0800.961
Distal stomach1875
Whole stomach934
Post-operative pathological stagingI-II12510.0220.883
III-IV1976
Serum PCT level on day 1 post-surgery (g/mL)0.99 ± 0.330.71 ± 0.118.0200.000
Serum CRP level on day 1 post-surgery (mg/L)173.14 ± 32.45106.69 ± 20.4614.2660.000
Serum TBil level on day 1 post-surgery (μmol/L)20.83 ± 4.1817.69 ± 4.133.7860.000